{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:01:50Z","timestamp":1777982510995,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00520-026-10507-2","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T09:23:46Z","timestamp":1772529826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gait as a quantitative indicator of the severity of chemotherapy-induced peripheral neuropathy: a pilot study"],"prefix":"10.1007","volume":"34","author":[{"given":"Serena Jiyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salahadin","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"10507_CR1","doi-asserted-by":"crossref","unstructured":"Kerckhove N, Collin A, Cond\u00e9 S, Chaleteix C, Pezet D, Balayssac D (2017) Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review. Front Pharmacol 8. Available from:   http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00086\/full.\u00a0Accessed 30 Dec 2025","DOI":"10.3389\/fphar.2017.00086"},{"key":"10507_CR2","doi-asserted-by":"crossref","unstructured":"Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-Oncol 14(suppl 4):iv45\u201354. Available from: https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nos203.\u00a0Accessed 30 Dec 2025","DOI":"10.1093\/neuonc\/nos203"},{"key":"10507_CR3","doi-asserted-by":"crossref","unstructured":"Banach M, Juranek JK, Zygulska AL (2017) Chemotherapy\u2010induced neuropathies\u2014a growing problem for patients and health care providers. Brain Behav 7(1):e00558. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/brb3.558.\u00a0Accessed 30 Dec 2025","DOI":"10.1002\/brb3.558"},{"key":"10507_CR4","doi-asserted-by":"crossref","unstructured":"Petrovic M, Maganaris CN, Bowling FL, Boulton AJM, Reeves ND (2019) Vertical displacement of the centre of mass during walking in people with diabetes and diabetic neuropathy does not explain their higher metabolic cost of walking. J Biomech 83:85\u201390. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021929018308625. [cited 2025 Jan 28]","DOI":"10.1016\/j.jbiomech.2018.11.027"},{"key":"10507_CR5","doi-asserted-by":"crossref","unstructured":"Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F (2006) Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 33(1):15\u201349. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775405004938. [cited 2024 Dec 31]","DOI":"10.1053\/j.seminoncol.2005.12.010"},{"issue":"7","key":"10507_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1001\/jamaneurol.2016.0383","volume":"73","author":"NA Kolb","year":"2016","unstructured":"Kolb NA, Smith AG, Singleton JR, Beck SL, Stoddard GJ, Brown S et al (2016) The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA Neurol 73(7):860\u2013866","journal-title":"JAMA Neurol"},{"key":"10507_CR7","doi-asserted-by":"crossref","unstructured":"Marshall TF, Zipp GP, Battaglia F, Moss R, Bryan S (2017) Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment. J Cancer Res Pract 4(4):134\u20138. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2311300616301975. [cited 2024 Dec 31]","DOI":"10.1016\/j.jcrpr.2017.03.005"},{"key":"10507_CR8","doi-asserted-by":"crossref","unstructured":"Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J et al (2013) Chemotherapy\u2010induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63(6):419\u2013437. Available from: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.3322\/caac.21204.\u00a0Accessed 30 Dec 2025","DOI":"10.3322\/caac.21204"},{"key":"10507_CR9","doi-asserted-by":"crossref","unstructured":"Tofthagen C, Overcash J, Kip K (2012) Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer 20(3):583\u20139. Available from: http:\/\/link.springer.com\/10.1007\/s00520-011-1127-7. [cited 2024 Dec 31]","DOI":"10.1007\/s00520-011-1127-7"},{"key":"10507_CR10","doi-asserted-by":"crossref","unstructured":"McCrary JM, Goldstein D, Wyld D, Henderson R, Lewis CR, Park SB (2019) Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test. J Cancer Surviv 13(4):495\u2013502. Available from:   http:\/\/link.springer.com\/10.1007\/s11764-019-00769-7.\u00a0Accessed 30 Dec 2025","DOI":"10.1007\/s11764-019-00769-7"},{"key":"10507_CR11","doi-asserted-by":"crossref","unstructured":"M\u00fcller J, Ringhof S, Vollmer M, J\u00e4ger LB, Stein T, Weiler M et al (2020) Out of balance \u2013 postural control in cancer patients before and after neurotoxic chemotherapy. Gait Posture 77:156\u201363. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966636220300138.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.gaitpost.2020.01.012"},{"issue":"23","key":"10507_CR12","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1200\/JCO.2016.71.3552","volume":"35","author":"KM Winters-Stone","year":"2017","unstructured":"Winters-Stone KM, Horak F, Jacobs PG, Trubowitz P, Dieckmann NF, Stoyles S et al (2017) Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol Off J Am Soc Clin Oncol 35(23):2604\u20132612","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10507_CR13","doi-asserted-by":"crossref","unstructured":"Bakitas MA (2007) Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res 56(5):323\u201331. Available from:  https:\/\/journals.lww.com\/00006199-200709000-00005.\u00a0Accessed 30 Dec 2025","DOI":"10.1097\/01.NNR.0000289503.22414.79"},{"key":"10507_CR14","doi-asserted-by":"crossref","unstructured":"Salgado TM, Quinn CS, Krumbach EK, Wenceslao I, Gonzalez M, Reed HL et al (2020) Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study. Support Care Cancer 28(9):4163\u20134172. Available from: http:\/\/link.springer.com\/10.1007\/s00520-019-05254-6.\u00a0Accessed 30 Dec 2025","DOI":"10.1007\/s00520-019-05254-6"},{"key":"10507_CR15","doi-asserted-by":"crossref","unstructured":"Alberti P, Rossi E, Cornblath DR, Merkies ISJ, Postma TJ, Frigeni B et al (2014) Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol 25(1):257\u2013264. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419359356.\u00a0Accessed 30 Dec 2025","DOI":"10.1093\/annonc\/mdt409"},{"key":"10507_CR16","doi-asserted-by":"crossref","unstructured":"In Collaboration with the CI-PeriNomS Group, Kieffer JM, Postma TJ, Van De Poll-Franse L, Mols F, Heimans JJ et al (2017) Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20). Qual Life Res 26(11):2999\u20133010. Available from:   http:\/\/link.springer.com\/10.1007\/s11136-017-1626-1.  [cited 2025 Jan 25]","DOI":"10.1007\/s11136-017-1626-1"},{"key":"10507_CR17","doi-asserted-by":"crossref","unstructured":"Lavoie Smith E, Haupt R, Kelly J, Lee D, Kanzawa-Lee G, Knoerl R et al (2017) The content validity of a chemotherapy-induced peripheral neuropathy patient-reported outcome measure. Oncol Nurs Forum 44(5):580\u2013588. Available from:  http:\/\/onf.ons.org\/onf\/44\/5\/content-validity-chemotherapy-induced-peripheral-neuropathy-patient-reported-outcome.\u00a0Accessed 30 Dec 2025","DOI":"10.1188\/17.ONF.580-588"},{"key":"10507_CR18","doi-asserted-by":"crossref","unstructured":"Lavoie Smith EM, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL (2013) Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Qual Life Res 22(10):2787\u20132799. Available from: http:\/\/link.springer.com\/10.1007\/s11136-013-0379-8.\u00a0Accessed 30 Dec 2025","DOI":"10.1007\/s11136-013-0379-8"},{"key":"10507_CR19","doi-asserted-by":"crossref","unstructured":"Smith EML, Zanville N, Kanzawa-Lee G, Donohoe C, Bridges C, Loprinzi C et al (2019) Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire\u2013Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data. Support Care Cancer 27(7):2599\u20132608. Available from:   http:\/\/link.springer.com\/10.1007\/s00520-018-4553-y. [cited 2025 Jan 25]","DOI":"10.1007\/s00520-018-4553-y"},{"key":"10507_CR20","doi-asserted-by":"crossref","unstructured":"Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ et al (2017) Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients. Breast Cancer Res Treat 164(1):69\u201377. Available from:   http:\/\/link.springer.com\/10.1007\/s10549-017-4230-8.\u00a0Accessed 30 Dec 2025","DOI":"10.1007\/s10549-017-4230-8"},{"key":"10507_CR21","doi-asserted-by":"crossref","unstructured":"Hsieh KL, Trinh L, Sosnoff JJ (2019) Gait variability is altered in cancer survivors with self-reported neuropathy. Gait Posture 72:206\u201310. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966636219300827.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.gaitpost.2019.06.014"},{"key":"10507_CR22","doi-asserted-by":"crossref","unstructured":"Lin KY, Chen PS, Lin CF (2024) Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer. BMC Gastroenterol  24(1):154. Available from:  https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03227-6. [cited 2026 Jan 4]","DOI":"10.1186\/s12876-024-03227-6"},{"key":"10507_CR23","doi-asserted-by":"crossref","unstructured":"Hollman JH, McDade EM, Petersen RC (2011) Normative spatiotemporal gait parameters in older adults. Gait Posture 34(1):111\u2013118. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966636211001019.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.gaitpost.2011.03.024"},{"key":"10507_CR24","doi-asserted-by":"crossref","unstructured":"Vu PD, McDonough KE, Dougherty PM, D\u2019Souza RS, Javed S (2024) Psychophysical and functional outcomes in chemotherapy-induced peripheral neuropathy after spinal cord stimulation: a narrative review and case series. Neuromodulation Technol Neural Interface 27(8):1305\u20131320. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109471592400134X.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.neurom.2024.06.006"},{"issue":"1","key":"10507_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41687-020-0180-8","volume":"4","author":"TR Mendoza","year":"2020","unstructured":"Mendoza TR, Williams LA, Shi Q, Wang XS, Bamidele O, Woodruff JF et al (2020) The Treatment-induced Neuropathy Assessment Scale (TNAS): a psychometric update following qualitative enrichment. J Patient-Rep Outcomes 4(1):15","journal-title":"J Patient-Rep Outcomes"},{"key":"10507_CR26","doi-asserted-by":"crossref","unstructured":"Bruening DA, Baird AR, Weaver KJ, Rasmussen AT (2020) Whole body kinematic sex differences persist across non-dimensional gait speeds. Srinivasan M, editor. PLOS ONE 15(8):e0237449. Available from:   https:\/\/dx.plos.org\/10.1371\/journal.pone.0237449.\u00a0Accessed 30 Dec 2025","DOI":"10.1371\/journal.pone.0237449"},{"key":"10507_CR27","doi-asserted-by":"crossref","unstructured":"Ko S uk, Tolea MI, Hausdorff JM, Ferrucci L (2011) Sex-specific differences in gait patterns of healthy older adults: results from the Baltimore Longitudinal Study of Aging. J Biomech 44(10):1974\u20131079. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192901100371X.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.jbiomech.2011.05.005"},{"key":"10507_CR28","doi-asserted-by":"crossref","unstructured":"R\u00f6ssler R, Wagner J, Knaier R, Rommers N, Kressig RW, Schmidt-Trucks\u00e4ss A et al (2024) Spatiotemporal gait characteristics across the adult lifespan: reference values from a healthy population \u2013 analysis of the COmPLETE cohort study. Gait Posture 109:101\u2013118. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966636224000043.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.gaitpost.2024.01.005"},{"key":"10507_CR29","doi-asserted-by":"crossref","unstructured":"Stansfield B, Hawkins K, Adams S, Bhatt H (2018) A mixed linear modelling characterisation of gender and speed related changes in spatiotemporal and kinematic characteristics of gait across a wide speed range in healthy adults. Med Eng Phys 60:94\u2013102. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350453318301243.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.medengphy.2018.07.015"},{"key":"10507_CR30","doi-asserted-by":"crossref","unstructured":"Rattanakrong N, Promma N, Saraboon C, Waongenngarm P (2022) Physical impairments, sensory disturbance, and functional ability in a cancer patient with and without chemotherapy-induced peripheral neuropathy symptoms. Support Care Cancer 30(6):5055\u20135062. Available from:   https:\/\/link.springer.com\/10.1007\/s00520-022-06927-5.\u00a0Accessed 30 Dec 2025","DOI":"10.1007\/s00520-022-06927-5"},{"key":"10507_CR31","doi-asserted-by":"crossref","unstructured":"Beaulieu ML, M\u00fcller MLTM, Bohnen NI. Peripheral neuropathy is associated with more frequent falls in Parkinson\u2019s disease. Parkinsonism Relat Disord [Internet]. 2018 Sept [cited 2025 Apr 11];54:46\u201350. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802018301512","DOI":"10.1016\/j.parkreldis.2018.04.006"},{"key":"10507_CR32","doi-asserted-by":"crossref","unstructured":"Hanewinckel R, Drenthen J, Verlinden VJA, Darweesh SKL, Van Der Geest JN, Hofman A et al (2017) Polyneuropathy relates to impairment in daily activities, worse gait, and fall-related injuries. Neurology 89(1):76\u201383. Available from:   https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000004067.\u00a0Accessed 30 Dec 2025","DOI":"10.1212\/WNL.0000000000004067"},{"key":"10507_CR33","doi-asserted-by":"crossref","unstructured":"Henderson AD, Johnson AW, Ridge ST, Egbert JS, Curtis KP, Berry LJ et al (2019) Diabetic gait is not just slow gait: gait compensations in diabetic neuropathy. J Diabetes Res 2019:1\u20139. Available from:  https:\/\/www.hindawi.com\/journals\/jdr\/2019\/4512501\/.\u00a0Accessed 30 Dec 2025","DOI":"10.1155\/2019\/4512501"},{"key":"10507_CR34","doi-asserted-by":"crossref","unstructured":"Hulshof CM, Van Der Leeden M, Van Netten JJ, Gijssel M, Evers J, Bus SA et al (2024) The association between peripheral neuropathy and daily-life gait quality characteristics in people with diabetes. Gait Posture 114:152\u2013159. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966636224006118.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.gaitpost.2024.09.004"},{"key":"10507_CR35","doi-asserted-by":"crossref","unstructured":"Shin KJ, Kang JW, Sung KH, Park SH, Kim SE, Park KM et al (2021) Quantitative gait and postural analyses in patients with diabetic polyneuropathy. J Diabetes Complications 35(4):107857. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872721000118.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.jdiacomp.2021.107857"},{"key":"10507_CR36","doi-asserted-by":"crossref","unstructured":"Monfort SM, Pan X, Loprinzi CL, Lustberg MB, Chaudhari AMW (2019) Exploring the roles of central and peripheral nervous system function in gait stability: preliminary insights from cancer survivors. Gait Posture 71:62\u20138. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966636218316382.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.gaitpost.2019.04.002"},{"key":"10507_CR37","doi-asserted-by":"crossref","unstructured":"Wright MJ, Twose DM, Gorter JW (2017) Gait characteristics of children and youth with chemotherapy induced peripheral neuropathy following treatment for acute lymphoblastic leukemia. Gait Posture 58:139\u2013145. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096663621730187X.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.gaitpost.2017.05.004"},{"key":"10507_CR38","doi-asserted-by":"crossref","unstructured":"Menant JC, Goldstein D, Au K, Trinh T, Van Schooten KS, McCrary JM et al (2021) Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy. Gait Posture 89:178\u2013185. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966636221002514.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.gaitpost.2021.07.010"},{"key":"10507_CR39","doi-asserted-by":"crossref","unstructured":"Richardson JK, Eckner JT, Allet L, Kim H, Ashton-Miller JA (2017) Complex and simple clinical reaction times are associated with gait, balance, and major fall injury in older subjects with diabetic peripheral neuropathy. Am J Phys Med Rehabil 96(1):8\u201316. Available from:  https:\/\/journals.lww.com\/00002060-201701000-00002.\u00a0Accessed 30 Dec 2025","DOI":"10.1097\/PHM.0000000000000604"},{"key":"10507_CR40","doi-asserted-by":"crossref","unstructured":"Kang GE, Murphy TK, Kunik ME, Badr HJ, Workeneh BT, Yellapragada SV et al (2021) The detrimental association between fear of falling and motor performance in older cancer patients with chemotherapy-induced peripheral neuropathy. Gait Posture 88:161\u20136. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966636221002046.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.gaitpost.2021.05.022"},{"key":"10507_CR41","doi-asserted-by":"crossref","unstructured":"Zahiri M, Chen KM, Zhou H, Nguyen H, Workeneh BT, Yellapragada SV et al (2019) Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - toward an early diagnosis of CIPN. J Geriatr Oncol 10(6):960\u2013967. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406818303655.\u00a0Accessed 30 Dec 2025","DOI":"10.1016\/j.jgo.2019.01.010"},{"key":"10507_CR42","doi-asserted-by":"crossref","unstructured":"Dasari S, Bernard Tchounwou P (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u201378. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914005627. [cited 2025 Jan 20]","DOI":"10.1016\/j.ejphar.2014.07.025"},{"key":"10507_CR43","doi-asserted-by":"crossref","unstructured":"El\u2010Shami K, Oeffinger KC, Erb NL, Willis A, Bretsch JK, Pratt\u2010Chapman ML et al (2015) American Cancer Society Colorectal Cancer Survivorship Care Guidelines. CA Cancer J Clin 65(6):427\u201355. Available from:   https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.3322\/caac.21286.\u00a0Accessed 30 Dec 2025","DOI":"10.3322\/caac.21286"},{"key":"10507_CR44","doi-asserted-by":"crossref","unstructured":"McWhinney SR, Goldberg RM, McLeod HL (2009) Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther 8(1):10\u201316. Available from:  https:\/\/aacrjournals.org\/mct\/article\/8\/1\/10\/93265\/Platinum-neurotoxicity-pharmacogenetics.\u00a0Accessed 30 Dec 2025","DOI":"10.1158\/1535-7163.MCT-08-0840"},{"key":"10507_CR45","doi-asserted-by":"crossref","unstructured":"Areti A, Yerra VG, Naidu V, Kumar A (2014) Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol 2:289\u201395. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231714000214. [cited 2025 Jan 18]","DOI":"10.1016\/j.redox.2014.01.006"},{"key":"10507_CR46","doi-asserted-by":"crossref","unstructured":"Wozniak KM, Vornov JJ, Wu Y, Liu Y, Carozzi VA, Rodriguez-Menendez V et al (2018) Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery. Cancer Res 78(3):817\u201329. Available from:  https:\/\/aacrjournals.org\/cancerres\/article\/78\/3\/817\/632219\/Peripheral-Neuropathy-Induced-by-Microtubule. [cited 2025 Jan 27]","DOI":"10.1158\/0008-5472.CAN-17-1467"},{"key":"10507_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clinbiomech.2019.12.019","volume":"72","author":"GE Kang","year":"2020","unstructured":"Kang GE, Zhou H, Varghese V, Najafi B (2020) Characteristics of the gait initiation phase in older adults with diabetic peripheral neuropathy compared to control older adults. Clin Biomech 72:155\u2013160","journal-title":"Clin Biomech"},{"key":"10507_CR48","doi-asserted-by":"crossref","unstructured":"Dewitt B, Jalal H, Hanmer J (2020) Computing PROPr Utility Scores for PROMIS\u00ae Profile Instruments. Value Health 23(3):370\u20138. Available from:  https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301519351356. [cited 2025 Mar 10]","DOI":"10.1016\/j.jval.2019.09.2752"},{"key":"10507_CR49","doi-asserted-by":"crossref","unstructured":"Hanmer J, Dewitt B, Yu L, Tsevat J, Roberts M, Revicki D et al (2018) Cross-sectional validation of the PROMIS-preference scoring system. PLOS ONE 13(7):e0201093. Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0201093. [cited 2025 Mar 10]. (Luo N, editor)","DOI":"10.1371\/journal.pone.0201093"},{"key":"10507_CR50","doi-asserted-by":"crossref","unstructured":"Skolasky RL, Cizik AM, Jain A, Neuman BJ (2024) Measuring value in spine care using the PROMIS-preference scoring system. J Bone Jt Surg 106(1):21\u20139. Available from:   https:\/\/journals.lww.com\/10.2106\/JBJS.23.00113. [cited 2025 Mar 10]","DOI":"10.2106\/JBJS.23.00113"},{"key":"10507_CR51","doi-asserted-by":"crossref","unstructured":"Lindsay SE, Bauer J, Bouton D, Do P, Woodmark C, Sienko S et al (2022) Patient-reported outcome measurement information system (PROMIS) scores in pediatric idiopathic toe walkers. J Pediatr Orthop 42(8):e878\u2013e881. Available from: https:\/\/journals.lww.com\/10.1097\/BPO.0000000000002198.\u00a0Accessed 30 Dec 2025","DOI":"10.1097\/BPO.0000000000002198"},{"key":"10507_CR52","doi-asserted-by":"crossref","unstructured":"MacCarthy M, Heyn P, Tagawa A, Carollo J (2022) Walking speed and patient\u2010reported outcomes in young adults with cerebral palsy. Dev Med Child Neurol 64(10):1281\u20131288. Available from:   https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dmcn.15225.\u00a0Accessed 30 Dec 2025","DOI":"10.1111\/dmcn.15225"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10507-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10507-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10507-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:46:04Z","timestamp":1773215164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10507-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10507"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10507-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6666978\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted in accordance with the ethical standards set forth in the Declaration of Helsinki for research involving human participants. This study was approved by the MD Anderson Institutional Review Board Protocol 2024-0368.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}